Interchangeability of Gabapentin Generic Formulations in the Netherlands: a Comparative Bioavailability Study

Time

Tue, Mar 05 8:30AM
20

Title

Interchangeability of Gabapentin Generic Formulations in the Netherlands: a Comparative Bioavailability Study

Abstract Summary

This study was conducted in 2011-2012 in the Netherlands, and designed as a single dose (800mg tablet), four-treatment (the innovator and three registered generic gabapentin products), randomised, four-way crossover trial in 24 healthy volunteers under fasting conditions.

Poster Presenter

Yang Yu
MSc,
Maastricht University
Netherlands

© 2015 DIA